AbbVie
ABBV
287.90
+5.22
+1.85%
AbbVie
US · ABBV
#30 by market cap
Listed 1970
287.90
+5.22
+1.85%
Live - 5344 symbols - heartbeat 31s ago
· 2026-10-20 15:40
About AbbVie
AbbVie is a biopharmaceutical company focused on immunology (rheumatology, gastroenterology and dermatology), oncology including blood cancers, virology, neuroscience conditions such as Parkinson's disease, and other specialty areas. It was spun off from Abbott Laboratories in October 2011 and is headquartered in North Chicago, Illinois.
- Founded
- 2011
- CEO
- Mr. Robert A. Michael
- Employees
- 57,000
- Headquarters
- North Chicago, Illinois, United States of America
- Fiscal year end
- 12-31
- Website
- abbvie.com
Company profile
- Exchange
- US
- Symbol
- ABBV
- Market-cap rank
- #30
- Listing date
- 1970-01-01
- Market cap
- 508.75B
- Float cap
- 507.85B
- Shares out
- 1.77B
- Float shares
- 1.76B
Sectors & themes
Drug Manufacturers - General
Government Pension Fund of Norway
Global medical industry
US New Economic Stocks
Regular Savings Plan
Fractional Shares JP
Quote time 2026-10-20 15:40:11 · For reference only, not investment advice and not tailored to your situation.
patent cliff fears priced in years ago and the new drugs stepped up more than skeptics expected. dividend yield here is still doing a lot of the work for the stock.